Impact BioMedical Inc.

NYSEAM:IBO Stock Report

Market Cap: US$24.8m

Impact BioMedical Management

Management criteria checks 0/4

Impact BioMedical's CEO is Frank Heuszel, appointed in Apr 2023, has a tenure of 1.5 years. directly owns 0.83% of the company’s shares, worth $206.23K. The average tenure of the management team and the board of directors is 1.5 years and 2.6 years respectively.

Key information

Frank Heuszel

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership0.8%
Management average tenure1.5yrs
Board average tenure2.6yrs

Recent management updates

Recent updates


CEO

Frank Heuszel (68 yo)

1.5yrs

Tenure

Mr. Frank D. Heuszel, JD, Esq. serves as Chairman of the Board at Impact BioMedical Inc. He serves as the Chief Executive Officer at Impact BioMedical Inc. since April 2023 and Director since August 2020 a...


Leadership Team

NamePositionTenureCompensationOwnership
Frank Heuszel
Chairman & CEO1.5yrsno data0.83%
$ 206.2k
Todd Macko
CFO. Secretary & Treasurer3.8yrsno data0.0010%
$ 260.8
Mark Suseck
Chief Operating Officer1.2yrsno datano data

1.5yrs

Average Tenure

63yo

Average Age

Experienced Management: IBO's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Frank Heuszel
Chairman & CEO4.2yrsno data0.83%
$ 206.2k
Elise Brownell
Director3.8yrsno datano data
Christian Zimmerman
Independent Directorno datano datano data
Jason Grady
Directorless than a yearno data0.0016%
$ 392.4
David Keene
Independent Directorno datano datano data
Castel Hibbert
Independent Directorno datano datano data
Melissa Sims
Director1.4yrsno datano data

2.6yrs

Average Tenure

64yo

Average Age

Experienced Board: IBO's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.